Bank of Nova Scotia’s Allergan plc AGN.PRA Stock Holding History

Bank of Nova Scotia’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-5,000	Closed	-$2.93M	–	1054
2017 Q4	$2.93M	Buy	5,000 +3,222	+181%	+$2.08M	0.01%	507
2017 Q3	$1.32M	Hold	1,778	–	–	0.01%	693
2017 Q2	$1.54M	Buy	+1,778	New	+$1.49M	0.01%	684
2017 Q1	–	Sell	-1,500	Closed	-$1.15M	–	950
2016 Q4	$1.15M	Buy	+1,500	New	+$1.13M	0.01%	461

Other funds holding AGN.PRA

PWS

Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Bank of Nova Scotia's AGN.PRA Position: Q1 2018 in Review

Bank of Nova Scotia sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 5,000 shares — an estimated $2.93M sold.

Bank of Nova Scotia first reported a position in AGN.PRA in Q4 2016 and held it in 4 quarters. The position peaked at $2.93M in Q4 2017. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

Bank of Nova Scotia reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
Bank of Nova Scotia sold 5,000 Allergan plc shares in Q1 2018, an estimated $2.93M.
Bank of Nova Scotia first reported a position in Allergan plc in Q4 2016 and held it in 4 quarters.
Bank of Nova Scotia's Allergan plc position peaked at $2.93M in Q4 2017.
1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Bank of Nova Scotia's 13F filing for Q1 2018, filed 15 May 2018.